16 April 2015
Scientists in Ufa, in the Volga region of Bashkortostan, have come up with a combined vaccine for two different types of meningitis, the website of the Vesti TV channel reported . There have traditionally been separate vaccines for each of the types.
This is said to be a joint product by the Ufa biochemical researchers and their Moscow-based colleagues.
The new vaccine is designed to prevent meningococcal meningitis of the A and C types, one of the most dangerous among infections. The disease may be accompanied by sepsis and bring meningitis to the mucous membrane of nasal pharynx and the brain. The mortality rate is high, and so are serious complications.
An experimental series of the new drug candidate is currently undergoing preclinical trials. The bulk of research into its toxicity and immunogenicity was completed by the end of last year already. The future drug will be “much less expensive than international analogs and won’t be second to those in quality,” the source said.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024